Source BioScience PLC Rule 2.10 Announcement (1995J)
07 Septiembre 2016 - 4:55AM
UK Regulatory
TIDMSBS
RNS Number : 1995J
Source BioScience PLC
07 September 2016
7 September 2016
Source BioScience plc
(or "the Company")
Rule 2.10 - Number of Relevant Securities in Issue
Pursuant to Rule 2.10 of the Code, Source BioScience confirms
that there are 349,351,081 ordinary shares of 2 pence each in issue
with International Securities Identification Number
GB0009739649.
Enquiries
Source BioScience plc
Dr Nick Ash, Company Secretary
Tel: +44 (0) 115 973 9010
Email: enquiries@sourcebioscience.com
www.sourcebioscience.com
About Source BioScience:
Source BioScience plc (LSE: SBS) is a trusted provider of state
of the art Laboratory Services and Products to the healthcare and
clinical, life and applied sciences and biopharma industries. It is
an international business operating ten state of the art facilities
in five countries and with customers in over 90 countries
worldwide. The Group offers a complementary portfolio of Laboratory
Services and Products that share common technologies, laboratory
processes, infrastructure and expertise. These include Diagnostics,
DNA Sequencing and Genomics, Analytical and Regulated Services,
Clinical Products, Life Science Research Reagents and Controlled
Environment for a comprehensive range of applications. These
Laboratory Services and Products are provided to a large and
diverse customer base including the top 50 pharmaceutical
companies, leading universities and research institutes worldwide,
the UK NHS and other healthcare providers. The Group is listed on
the Premium Main Market of the London Stock Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RTTEANNXESAKEEF
(END) Dow Jones Newswires
September 07, 2016 05:55 ET (09:55 GMT)
Source Bioscience (LSE:SBS)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Source Bioscience (LSE:SBS)
Gráfica de Acción Histórica
De May 2023 a May 2024
Real-Time news about Source Bio. (London Stock Exchange): 0 recent articles
Más de Source Bio. Artículos de Noticias